Osamu Togo

Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial

Tsutomu Takeuchi, Yoshiya Tanaka, Hisashi Yamanaka et al. · Modern Rheumatology · 2015 · 58 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Clinical benefit of 1-year certolizumab pegol (CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritis was observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial

Tatsuya Atsumi, Yoshiya Tanaka, Kazuhiko Yamamoto et al. · Annals of the Rheumatic Diseases · 2017 · 41 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Safety, pharmacokinetics, and pharmacodynamics of epratuzumab in Japanese patients with moderate-to-severe systemic lupus erythematosus: Results from a phase 1/2 randomized study

Tomomi Tsuru, Yoshiya Tanaka, Mitsumasa Kishimoto et al. · Modern Rheumatology · 2015 · 19 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

<i><b>Post-hoc</b></i> analysis showing better clinical response with the loading dose of certolizumab pegol in Japanese patients with active rheumatoid arthritis

Tsutomu Takeuchi, Kazuhiko Yamamoto, Hisashi Yamanaka et al. · Modern Rheumatology · 2015 · 11 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Daridorexant in Japanese patients with insomnia disorder: A phase 3, randomized, double-blind, placebo-controlled study

Naohisa Uchimura, Mitsutaka Taniguchi, Yu Ariyoshi et al. · Sleep Medicine · 2024 · 10 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17